Sirois Pharmaceuticals Private Limited
About Sirois Pharmaceuticals Private Limited
Data last updated:
Sirois Pharmaceuticals Private Limited was a private limited company based in Dehradun, Uttarakhand, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the manufacturing segment of the chemicals sector. It was incorporated on 02 July 2020.
The company was registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24290UR2020PTC011088. Its GSTIN is 05ABDCS8703K1Z6 (Uttarakhand).
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It was led by directors Kishor Joshi and Suresh Melkani.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at K.H No 1009/2 C.H.T Selaqui, Dehradun, Uttarakhand, India – 248011.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.78 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹45,820 (net margin 25.8%) and EBITDA of ₹67,379 (EBITDA margin 37.9%). Revenue has declined at a compounded annual rate (CAGR) of 33% over three years.
Company details
Contact details
Sirois Pharmaceuticals Private Limited's registered office is in Dehradun, Uttarakhand. Its e-mail address is in the company report.
- Email
- Registered AddressK.H No 1009/2 C.H.T Selaqui, Dehradun, Uttarakhand, India – 248011
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Sirois Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sirois Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Sirois Pharmaceuticals Private Limited
FY 2024 filings availableSirois Pharmaceuticals Private Limited reported revenue of ₹1.78 Lakh (up 2540843% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 33% over three years. EBITDA rose 151% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹67,379 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹45,820 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 37.9% | |||
| Net Profit Margin | 25.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Sirois Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sirois Pharmaceuticals Private Limited
Sirois Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kishor Joshi Also directs: Genford Drugs Private Limited, Joshi Drugs Private Limited | Director | 02 Jul 2020 | 6 Years 4 Months | As last reported |
| Suresh Melkani | Director | 02 Jul 2020 | 6 Years 4 Months | As last reported |
Legal cases
No court or tribunal cases involving Sirois Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sirois Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sirois Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05ABDCS8703K1Z6 | Uttarakhand | Active | 22 Aug 2020 |
To see the full GST registrations and return filing status of Sirois Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sirois Pharmaceuticals Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Sunil Dutt Joshi ceased to be Director on 01 Nov 2021.
Frequently asked questions
Sirois Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Sirois Pharmaceuticals was a private limited company based in Dehradun, Uttarakhand, India. The company worked in manufacturing, within the chemicals industry. It was incorporated on 02 July 2020 and is registered under CIN U24290UR2020PTC011088. The company has been struck off by the Registrar of Companies and is no longer operational.
Sirois Pharmaceuticals had 2 directors:
- Kishor Joshi - Director
- Suresh Melkani - Director
The CIN (Corporate Identification Number) of Sirois Pharmaceuticals is U24290UR2020PTC011088. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Sirois Pharmaceuticals is at K.H No 10092 C.H.T Selaqui, Dehradun, Uttarakhand, India – 248011.
Sirois Pharmaceuticals was incorporated on 02 July 2020. It is registered with the Registrar of Companies, Uttarakhand.
The latest financial statements of Sirois Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Sirois Pharmaceuticals is 05ABDCS8703K1Z6, registered in Uttarakhand.
Sirois Pharmaceuticals operated in the chemicals industry, in the manufacturing segment. It worked in this industry before it was struck off.
Sunil Dutt Joshi ceased to be Director on 01 Nov 2021. Kishor Joshi was appointed as Director on 02 Jul 2020. Suresh Melkani was appointed as Director on 02 Jul 2020.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
